Skip to content
Optionomics Free · No account needed

Options flow · Direxion Daily S&P Biotech Bear

LABD options flow

Last full session · September 22, 2026 · Delayed and summarised

Where the premium went

Call premium minus put premium, session by session.

15 sessions
Aug 12: $0 more on calls Aug 13: $0 more on calls Aug 18: $22 more on puts Aug 19: $0 more on calls Aug 20: $103.6K more on calls Aug 21: $33.3K more on puts Aug 24: $18.6K more on puts Aug 25: $14.2K more on puts Aug 27: $147.9K more on puts Aug 28: $99.9K more on puts Aug 31: $41.6K more on calls Sep 2: $62.7K more on calls Sep 4: $0 more on calls Sep 8: $15.5K more on calls Sep 22: $56.1K more on puts More on calls More on puts Largest net: $147.9K Aug 12 Sep 22

Above zero: more spent on calls. Below zero: more on puts. Bar heights share a scale within this stock's history; premium alone does not tell us whether a trade was bought or sold.

Put the activity in context

Derived readings from the same completed session.

Relative options cost

43%
43%

Options are priced about normally — higher than 43% of the last year for this stock

Most is riding on $6.50 and $7.00
the prices with the most contracts still open above and below
Trading far below its 52-week high
+10.6% over the last month
How to read these figures

Every reading here is one we computed from that session. The history plots the difference between aggregate call and put premium, scaled to the largest absolute reading in this window.

Institutional-looking activity is inferred from trade size and shape. Sweeps span multiple venues. Neither tells us who traded or guarantees a directional move.

Relative options cost compares this stock with its own past year. It is not the stock's implied volatility quoted as a percentage.